Metastatic Colorectal Cancers Withdrawn Phase 2 / 3 Trials for Aflibercept (DB08885)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01646554Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesTreatment